Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in Critical Limb Ischemia
NCT04229264Phase 3Unknown
- Sponsor
- Science Valley Research Institute
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in critical limb ischemia (CLI), sponsored by Science Valley Research Institute. Status: unknown.
02
Drugs
apixaban
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT04229264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04229264.